MITOXANTRONE INJECTION

Product Overview

About MITOXANTRONE INJECTION

MITOXANTRONE INJECTION is a potent pharmaceutical agent classified as an antineoplastic medication. Containing the active ingredient Mitoxantrone Hydrochloride, this injection is primarily utilized in the treatment of specific types of cancer and advanced neurological conditions. It functions as a cytotoxic agent, designed to interfere with the cellular processes of rapidly dividing cells, making it a critical component in specialized oncological and neurodegenerative therapeutic regimens.

Key Benefits & Uses

• Treatment of advanced-stage breast cancer in specific clinical settings.
• Management of acute myeloid leukemia (AML) in adult patients.
• Therapeutic application for certain types of aggressive lymphomas.
• Used in the management of advanced multiple sclerosis under strict medical supervision.

Active Ingredient & Action

The active ingredient in this medication is MITOXANTRONE (MITOXANTRONE HYDROCHLORIDE). It belongs to the anthracycline class of chemotherapy drugs. Its mechanism of action involves intercalating into DNA, which inhibits the enzyme topoisomerase II, thereby preventing DNA replication and transcription. This process effectively halts the proliferation of malignant or hyperactive cells.

Important Notes

MITOXANTRONE INJECTION must be administered strictly under the supervision of a qualified oncologist or neurologist. Common side effects may include myelosuppression, nausea, and alopecia. Patients should be monitored closely for cardiotoxicity. This medication is for professional clinical use only and must be handled according to strict pharmaceutical safety protocols.